Related Experiment Video
Updated: Dec 31, 2025
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Chemogenetic interactions in human cancer cells
Medina Colic1,2, Traver Hart1
1Department of Bioinformatics and Computational Biology and Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
Chemogenetic profiling enables the identification of genes that enhance or suppress the phenotypic effect of chemical compounds. Using this approach in cancer therapies could improve our ability to predict the response of specific tumor genotypes to chemotherapeutic agents, thus accelerating the development of personalized drug therapy. In the not so distant past, this strategy was only applied in model organisms because there was no feasible technology to thoroughly exploit desired genetic mutations and their impact on drug efficacy in human cells. Today, with the advent of CRISPR gene-editing technology and its application to pooled library screens in mammalian cells, chemogenetic screens are performed directly in human cell lines with high sensitivity and specificity. Chemogenetic profiling provides insights into drug mechanism-of-action, genetic vulnerabilities, and resistance mechanisms, all of which will help to accurately deliver the right drug to the right target in the right patient while minimizing side effects.
Insights
Chemogenetic profiling uses CRISPR gene editing to identify genes affecting drug response in human cells. This advances personalized cancer therapy by predicting treatment efficacy and minimizing side effects.
Area of Science:
- Genomics
- Pharmacology
- Cancer Biology
Background:
- Chemogenetic profiling identifies genes influencing drug responses.
- Historically limited to model organisms due to technological constraints.
- CRISPR gene editing now enables high-throughput screens in human cells.
Purpose of the Study:
- To leverage advanced chemogenetic profiling in human cell lines.
- To enhance prediction of tumor genotype response to chemotherapy.
- To accelerate personalized drug therapy development.
Main Methods:
- Utilizing CRISPR gene-editing technology for pooled library screens.
- Performing chemogenetic screens directly in human cell lines.
- Achieving high sensitivity and specificity in identifying genetic modulators of drug response.
Main Results:
- Identification of genes that enhance or suppress drug phenotypic effects.
- Gained insights into drug mechanisms of action.
- Uncovered genetic vulnerabilities and resistance mechanisms.
Conclusions:
- Chemogenetic profiling in human cells is now feasible and effective.
- This approach is crucial for precision medicine in oncology.
- Enables accurate drug targeting, improving patient outcomes and reducing toxicity.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:25Mutagenicity and Carcinogenicity
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:18Cancer
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:38Mitogens and the Cell Cycle